GILD•benzinga•April 28, 2022 at 08:56 PM

Gilead Sciences Q1 Results Surpass Street Expectation, FY22 Outlook Midpoint Trails Consensus

Gilead Sciences, Inc. (NASDAQ: GILD) reported firs

Read the full article from the original source for complete details and context.

Article published on April 28, 2022 by benzinga